Corrigendum to "Anti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis" [Int. Immunopharmacol. 28(1) (2015) 731-743]
Int Immunopharmacol. 2020 Nov:88:107019.
doi: 10.1016/j.intimp.2020.107019.
Epub 2020 Sep 23.
1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, People's Republic of China.
2 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, People's Republic of China; Chongqing Tree Gorges Medical College, Faculty of Basic Medicine, Department of Biochemistry, People's Republic of China.
3 Innovent Biologics, Inc., Suzhou, Jiangsu, People's Republic of China.
4 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, People's Republic of China; Innovent Biologics, Inc., Suzhou, Jiangsu, People's Republic of China.
5 Department of Immunology, Nankai University School of Medicine, Tianjin, People's Republic of China.
6 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, People's Republic of China. Electronic address: [email protected].